Kewin Siah
@kewinsiah.bsky.social
Gastroenterologist specializing in DGBIs. Adjunct A/Prof at the National University of Singapore. President of IBS Support Group Singapore. Passionate about IBS, constipation, gastroparesis, and gut health.
Pinned
Kewin Siah
@kewinsiah.bsky.social
· Jan 24
🌏 Join us in Jakarta for ANMA 2025 🇮🇩 — the premier neurogastroenterology event in Asia!
📆 4–6 September 2025
🏨 Ritz Carlton Mega Kuningan Hotel
🤝 In conjunction with IDDW 2025
Let’s advance #DGBI care together!
🔗 [https://iddwanma2025.com/]
#ANMA2025 #IDDW2025 #Neurogastroenterology #GIcare #Jakarta
📆 4–6 September 2025
🏨 Ritz Carlton Mega Kuningan Hotel
🤝 In conjunction with IDDW 2025
Let’s advance #DGBI care together!
🔗 [https://iddwanma2025.com/]
#ANMA2025 #IDDW2025 #Neurogastroenterology #GIcare #Jakarta
July 5, 2025 at 10:14 PM
The Korean🇰🇷 #IBS consensus is comprehensive, pragmatic, and harmonizes Western evidence with regional practice constraints, drug availability, and increasing psychosocial attention.
www.jnmjournal.org/journal/view...
#GIsky #DGNIsky
www.jnmjournal.org/journal/view...
#GIsky #DGNIsky
2025 Seoul Consensus on Clinical Practice Guidelines for Irritable Bowel Syndrome
Yonghoon Choi, Young Hoon Youn, Seung Joo Kang, Jeong Eun Shin, Young Sin Cho, Yoon Suk Jung, Seung Yong Shin, Cheal Wung Huh, Yoo Jin Lee, Hoon Sup Koo, Kwangwoo Nam, Hong Sub Lee, Dong Hyun Kim, Ye ...
www.jnmjournal.org
April 20, 2025 at 1:21 AM
The Korean🇰🇷 #IBS consensus is comprehensive, pragmatic, and harmonizes Western evidence with regional practice constraints, drug availability, and increasing psychosocial attention.
www.jnmjournal.org/journal/view...
#GIsky #DGNIsky
www.jnmjournal.org/journal/view...
#GIsky #DGNIsky
We’ve put this sticker up in our hospital loo for #WorldIBSDay—proud to partner with NUHS+ to shine a light on IBS‑C.
👉 nuhsplus.edu.sg/article/back...
#GISky #DGBISky
👉 nuhsplus.edu.sg/article/back...
#GISky #DGBISky
April 18, 2025 at 6:25 PM
We’ve put this sticker up in our hospital loo for #WorldIBSDay—proud to partner with NUHS+ to shine a light on IBS‑C.
👉 nuhsplus.edu.sg/article/back...
#GISky #DGBISky
👉 nuhsplus.edu.sg/article/back...
#GISky #DGBISky
🆕 2025 USMSTF Bowel Prep Recommendations:
✅ Split-dose still #1
✅ 2L preps now preferred 💧
✅ Same-day OK for PM scopes (not AM)
✅ Low-residue > clear liquid diet
❗ Aim for >90% adequate prep
🤔 Simethicone? Possibly helpful.
🔓 Full text: www.giejournal.org/article/S001...
#GIsky #MEdedsky
✅ Split-dose still #1
✅ 2L preps now preferred 💧
✅ Same-day OK for PM scopes (not AM)
✅ Low-residue > clear liquid diet
❗ Aim for >90% adequate prep
🤔 Simethicone? Possibly helpful.
🔓 Full text: www.giejournal.org/article/S001...
#GIsky #MEdedsky
April 1, 2025 at 9:19 PM
🆕 2025 USMSTF Bowel Prep Recommendations:
✅ Split-dose still #1
✅ 2L preps now preferred 💧
✅ Same-day OK for PM scopes (not AM)
✅ Low-residue > clear liquid diet
❗ Aim for >90% adequate prep
🤔 Simethicone? Possibly helpful.
🔓 Full text: www.giejournal.org/article/S001...
#GIsky #MEdedsky
✅ Split-dose still #1
✅ 2L preps now preferred 💧
✅ Same-day OK for PM scopes (not AM)
✅ Low-residue > clear liquid diet
❗ Aim for >90% adequate prep
🤔 Simethicone? Possibly helpful.
🔓 Full text: www.giejournal.org/article/S001...
#GIsky #MEdedsky
🧠💻 The AGA 2025 Guideline on CADe-assisted colonoscopy makes no recommendation—due to very low certainty in reducing #CRC incidence or mortality.
✅ ADR improve ⚠️ But more low-risk polyp detection → increased surveillance, cost & patient burden. #GiSky #GutSky
www.gastrojournal.org/article/S001...
✅ ADR improve ⚠️ But more low-risk polyp detection → increased surveillance, cost & patient burden. #GiSky #GutSky
www.gastrojournal.org/article/S001...
March 22, 2025 at 1:57 AM
🧠💻 The AGA 2025 Guideline on CADe-assisted colonoscopy makes no recommendation—due to very low certainty in reducing #CRC incidence or mortality.
✅ ADR improve ⚠️ But more low-risk polyp detection → increased surveillance, cost & patient burden. #GiSky #GutSky
www.gastrojournal.org/article/S001...
✅ ADR improve ⚠️ But more low-risk polyp detection → increased surveillance, cost & patient burden. #GiSky #GutSky
www.gastrojournal.org/article/S001...
Vibrating Capsule shows promise in treating Chronic Constipation! Low adverse events (2.9% bloating, 2.9% abdominal pain) and high patient satisfaction (83% convenient, 71% satisfied). Read more: (link unavailable) #GISky #MedSky #DGBI
👉https://pubmed.ncbi.nlm.nih.gov/40059867/
👉https://pubmed.ncbi.nlm.nih.gov/40059867/
The Vibrating Capsule: Safety and Tolerability in Patients With Chronic Idiopathic Constipation - PubMed
The Vibrating Capsule, a first in class treatment for CIC was found to be safe and well tolerated by patients in clinical trials. No patient discontinued treatment due to adverse events.
pubmed.ncbi.nlm.nih.gov
March 15, 2025 at 9:44 PM
📚 New Research: Linaclotide outperforms Lactulose for treating Functional Dyspepsia + IBS-C overlap. 🌟
✅ 87.2% of patients on Linaclotide reported symptom relief vs just 54.2% on Lactulose
📈 Bloating, abdominal discomfort, stool frequency
🔬 pubmed.ncbi.nlm.nih.gov/40079184/
#GutSky #IBSSky #DGBI
✅ 87.2% of patients on Linaclotide reported symptom relief vs just 54.2% on Lactulose
📈 Bloating, abdominal discomfort, stool frequency
🔬 pubmed.ncbi.nlm.nih.gov/40079184/
#GutSky #IBSSky #DGBI
Efficacy of Linaclotide in Functional Dyspepsia and Constipation-Predominant Irritable Bowel Syndrome Overlap: A Randomized Trial - PubMed
ClinicalTrials.gov: NCT05134584.
pubmed.ncbi.nlm.nih.gov
March 13, 2025 at 1:39 PM
📚 New Research: Linaclotide outperforms Lactulose for treating Functional Dyspepsia + IBS-C overlap. 🌟
✅ 87.2% of patients on Linaclotide reported symptom relief vs just 54.2% on Lactulose
📈 Bloating, abdominal discomfort, stool frequency
🔬 pubmed.ncbi.nlm.nih.gov/40079184/
#GutSky #IBSSky #DGBI
✅ 87.2% of patients on Linaclotide reported symptom relief vs just 54.2% on Lactulose
📈 Bloating, abdominal discomfort, stool frequency
🔬 pubmed.ncbi.nlm.nih.gov/40079184/
#GutSky #IBSSky #DGBI
"Constipation is a common GI symptom in pure autonomic failure, affecting nearly half of patients. It often shows up alongside other autonomic issues, highlighting the complexity of managing this condition. 🧠🚽 #NeurologySky #GutSky #ANSSky #https://pubmed.ncbi.nlm.nih.gov/40053259/
March 10, 2025 at 1:54 AM
"Constipation is a common GI symptom in pure autonomic failure, affecting nearly half of patients. It often shows up alongside other autonomic issues, highlighting the complexity of managing this condition. 🧠🚽 #NeurologySky #GutSky #ANSSky #https://pubmed.ncbi.nlm.nih.gov/40053259/
🚨 What raises your risk of #IBS? A new umbrella review of 69 systematic reviews highlights key factors: female gender, anxiety, depression & gastroenteritis. How can we improve prevention? #GutHealth #DGBISky #GISky
March 4, 2025 at 11:39 PM
🚨 What raises your risk of #IBS? A new umbrella review of 69 systematic reviews highlights key factors: female gender, anxiety, depression & gastroenteritis. How can we improve prevention? #GutHealth #DGBISky #GISky
🚀 A breakthrough in motility testing! The #AtmoCapsule emerges as a solid alternative to the discontinued #SmartPill, showing strong correlation for gastric emptying & colonic transit times. A new era for GI transit assessment? #DrGutBrainExplains #GISky #DGBISky
🔓 www.cghjournal.org/article/S154...
🔓 www.cghjournal.org/article/S154...
March 4, 2025 at 11:25 PM
🚀 A breakthrough in motility testing! The #AtmoCapsule emerges as a solid alternative to the discontinued #SmartPill, showing strong correlation for gastric emptying & colonic transit times. A new era for GI transit assessment? #DrGutBrainExplains #GISky #DGBISky
🔓 www.cghjournal.org/article/S154...
🔓 www.cghjournal.org/article/S154...
🔥New study: Psychological stress can break oral tolerance to food, triggering IgE-mediated mast cell activation & gut pain hypersensitivity—offering insights into stress-induced IBS. #GISky #GutSky #DGBI #MedSky
📃https://els-jbs-prod-cdn.jbs.elsevierhealth.com/article/S0016-5085(25)00371-3/fulltext
📃https://els-jbs-prod-cdn.jbs.elsevierhealth.com/article/S0016-5085(25)00371-3/fulltext
February 22, 2025 at 11:24 PM
Kudos to @AndySamberg & @BowenYang for tackling anxiety & #IBS in their #SNL song! Using comedy to break down stigma & spark conversations. Authentic representation matters! #MentalHealthMatters #GutHealthMatters #GITwitter
👉https://youtu.be/k94SUJ8UMKk?si=1QZhXfJO-L5RgDy_
👉https://youtu.be/k94SUJ8UMKk?si=1QZhXfJO-L5RgDy_
February 20, 2025 at 2:32 PM
Kudos to @AndySamberg & @BowenYang for tackling anxiety & #IBS in their #SNL song! Using comedy to break down stigma & spark conversations. Authentic representation matters! #MentalHealthMatters #GutHealthMatters #GITwitter
👉https://youtu.be/k94SUJ8UMKk?si=1QZhXfJO-L5RgDy_
👉https://youtu.be/k94SUJ8UMKk?si=1QZhXfJO-L5RgDy_
New study shows an IgG-based elimination diet improved #IBS symptoms in 59.6% of patients vs 42.1% on a sham diet (n=223). Interesting, but subgroup analysis suggests it may work better for IBS-C and IBS-M than IBS-D. #GISky #GutSky #DGBI pubmed.ncbi.nlm.nih.gov/39894284/
February 10, 2025 at 5:54 PM
New study shows an IgG-based elimination diet improved #IBS symptoms in 59.6% of patients vs 42.1% on a sham diet (n=223). Interesting, but subgroup analysis suggests it may work better for IBS-C and IBS-M than IBS-D. #GISky #GutSky #DGBI pubmed.ncbi.nlm.nih.gov/39894284/
Advanced #Parkinson’s led to severe colonic dysmotility, fecal impaction, & kidney issues in a 77-yr-old. Treated with rectal tube + meds, but no cure for alpha-synuclein damage. 🚨 Early recognition key! #stoolcankill 🧠💩 #GISky #GutSky #constipation #DGBI #FGID pubmed.ncbi.nlm.nih.gov/39917098/
February 8, 2025 at 11:34 PM
Advanced #Parkinson’s led to severe colonic dysmotility, fecal impaction, & kidney issues in a 77-yr-old. Treated with rectal tube + meds, but no cure for alpha-synuclein damage. 🚨 Early recognition key! #stoolcankill 🧠💩 #GISky #GutSky #constipation #DGBI #FGID pubmed.ncbi.nlm.nih.gov/39917098/
Are you thinking of signing up for #BlueSky?
▶️Use Sky follower bridge extension to follow people on bluesky that you follow on twitter! I
www.sky-follower-bridge.dev/get-started....
▶️Follow me! @kewinsiah.bsky.social
Check out the #BlueSky's #DGBI Starter Pack also! 🌟➡️https://go.bsky.app/5PZzEvd
▶️Use Sky follower bridge extension to follow people on bluesky that you follow on twitter! I
www.sky-follower-bridge.dev/get-started....
▶️Follow me! @kewinsiah.bsky.social
Check out the #BlueSky's #DGBI Starter Pack also! 🌟➡️https://go.bsky.app/5PZzEvd
Sky Follower Bridge
Instantly find and follow the same users from your 𝕏 followers on Bluesky
www.sky-follower-bridge.dev
February 8, 2025 at 3:25 AM
Are you thinking of signing up for #BlueSky?
▶️Use Sky follower bridge extension to follow people on bluesky that you follow on twitter! I
www.sky-follower-bridge.dev/get-started....
▶️Follow me! @kewinsiah.bsky.social
Check out the #BlueSky's #DGBI Starter Pack also! 🌟➡️https://go.bsky.app/5PZzEvd
▶️Use Sky follower bridge extension to follow people on bluesky that you follow on twitter! I
www.sky-follower-bridge.dev/get-started....
▶️Follow me! @kewinsiah.bsky.social
Check out the #BlueSky's #DGBI Starter Pack also! 🌟➡️https://go.bsky.app/5PZzEvd
#Stoolcankill: Rare case of ileal fecaloma causing small bowel obstruction in a 60yo 🧓with chronic #constipation. Surgical intervention successfully resolved the obstruction. Highlights importance of considering fecaloma in SBO differentials. #GiSky #Gutsky #DGBI pubmed.ncbi.nlm.nih.gov/39905511/
February 7, 2025 at 10:25 PM
#Stoolcankill: Rare case of ileal fecaloma causing small bowel obstruction in a 60yo 🧓with chronic #constipation. Surgical intervention successfully resolved the obstruction. Highlights importance of considering fecaloma in SBO differentials. #GiSky #Gutsky #DGBI pubmed.ncbi.nlm.nih.gov/39905511/
Reposted by Kewin Siah
We strongly suggest that academic publishers and other platforms that host research rapidly implement a Share to Bluesky button for their articles. Here's how:
docs.bsky.app/docs/advance...
#AcademicSky #HigherEd #Altmetrics
docs.bsky.app/docs/advance...
#AcademicSky #HigherEd #Altmetrics
Action Intent Links | Bluesky
Authors, websites, and apps can use action intent links to implement "Share on Bluesky" buttons, or similar in-app actions. Logged-in users will be directed to the corresponding action view in the Blu...
docs.bsky.app
November 18, 2024 at 2:48 PM
We strongly suggest that academic publishers and other platforms that host research rapidly implement a Share to Bluesky button for their articles. Here's how:
docs.bsky.app/docs/advance...
#AcademicSky #HigherEd #Altmetrics
docs.bsky.app/docs/advance...
#AcademicSky #HigherEd #Altmetrics
Reposted by Kewin Siah
Gastroparesis: the chronic feeling of bloating, nausea & upper GI discomfort. With #GLP1 helping to boost the prevalence to 1-2% of the population, is it finally getting the attention it deserves?
🧵⬇️
#gisky #gastrosky #gastroparesis #IBD
🧵⬇️
#gisky #gastrosky #gastroparesis #IBD
November 19, 2024 at 10:51 AM
Gastroparesis: the chronic feeling of bloating, nausea & upper GI discomfort. With #GLP1 helping to boost the prevalence to 1-2% of the population, is it finally getting the attention it deserves?
🧵⬇️
#gisky #gastrosky #gastroparesis #IBD
🧵⬇️
#gisky #gastrosky #gastroparesis #IBD
Digital eHealth vs onsite 2-day IBS education: Digital program significantly ⬇️ symptom severity in 41% of pts & improved QoL, anxiety, depression. Both interventions scored high on client satisfaction. eHealth is a viable, for IBS self-management. #GutSky #GISky humanfactors.jmir.org/2025/1/e43618
February 4, 2025 at 6:29 AM
Digital eHealth vs onsite 2-day IBS education: Digital program significantly ⬇️ symptom severity in 41% of pts & improved QoL, anxiety, depression. Both interventions scored high on client satisfaction. eHealth is a viable, for IBS self-management. #GutSky #GISky humanfactors.jmir.org/2025/1/e43618
#Gastroparesis Dx requires Sx like nausea/vomiting; asymptomatic cases excluded. N&V are key; bloating, pain less linked to severity. Overlaps with #FDyspepsia, but distinct patterns. QoL, mental health impacted. Weight loss not always present. #GutSky #GISky www.thelancet.com/journals/lan...
February 4, 2025 at 3:39 AM
#Gastroparesis Dx requires Sx like nausea/vomiting; asymptomatic cases excluded. N&V are key; bloating, pain less linked to severity. Overlaps with #FDyspepsia, but distinct patterns. QoL, mental health impacted. Weight loss not always present. #GutSky #GISky www.thelancet.com/journals/lan...
🚨 New @AmerGastroAssn update! 🚨 Screening & surveillance are key for #gastric cancer prevention in high-risk U.S. groups. Endoscopy + H. pylori eradication = crucial steps. Personalized risk-based approach needed. 🔗 doi.org/10.1053/j.ga... #GISky #medsky #GutSky
February 1, 2025 at 2:31 PM
🚨 New @AmerGastroAssn update! 🚨 Screening & surveillance are key for #gastric cancer prevention in high-risk U.S. groups. Endoscopy + H. pylori eradication = crucial steps. Personalized risk-based approach needed. 🔗 doi.org/10.1053/j.ga... #GISky #medsky #GutSky
A Japanese multicenter study found that comorbid #constipation was linked to a 90%⬆️mortality risk in #HeartFailure pts (P < 0.001) Among 715 patients, those with constipation had worse 2-year survival and higher cardiovascular mortality. #GISky #CardioSky #HeartSky
pubmed.ncbi.nlm.nih.gov/39877026/
pubmed.ncbi.nlm.nih.gov/39877026/
Impact of comorbid constipation on the survival of patients with heart failure: a multicenter, prospective cohort study conducted in Japan - PubMed
Constipation can negatively affect the survival of patients with heart failure. Although the causal link between constipation and decreased survival remains unclear, identifying comorbid constipation ...
pubmed.ncbi.nlm.nih.gov
January 31, 2025 at 10:47 PM
A Japanese multicenter study found that comorbid #constipation was linked to a 90%⬆️mortality risk in #HeartFailure pts (P < 0.001) Among 715 patients, those with constipation had worse 2-year survival and higher cardiovascular mortality. #GISky #CardioSky #HeartSky
pubmed.ncbi.nlm.nih.gov/39877026/
pubmed.ncbi.nlm.nih.gov/39877026/
🔍 Overtesting in IBS? A study of 26,732 IBS patients found that 85.3% of advanced serologic tests were ordered by GIs, yet only 12.5% followed guidelines, with a mere 2.1% positive rate. 💰 $39K wasted on unnecessary tests. Stick to Rome IV criteria! #GISky #GutSky
pubmed.ncbi.nlm.nih.gov/39853154/
pubmed.ncbi.nlm.nih.gov/39853154/
Specialty laboratory testing for chronic abdominal pain in irritable bowel syndrome - PubMed
The findings emphasize the effectiveness and importance of adhering to Rome IV criteria, as advanced testing often fails to improve diagnostic accuracy and increases unnecessary healthcare costs.
pubmed.ncbi.nlm.nih.gov
January 31, 2025 at 10:01 PM
🔍 Overtesting in IBS? A study of 26,732 IBS patients found that 85.3% of advanced serologic tests were ordered by GIs, yet only 12.5% followed guidelines, with a mere 2.1% positive rate. 💰 $39K wasted on unnecessary tests. Stick to Rome IV criteria! #GISky #GutSky
pubmed.ncbi.nlm.nih.gov/39853154/
pubmed.ncbi.nlm.nih.gov/39853154/